Thomas K. Equels - Mar 3, 2022 Form 4 Insider Report for AIM ImmunoTech Inc. (AIM)

Role
CEO & President, Director
Signature
Thomas K. Equels
Stock symbol
AIM
Transactions as of
Mar 3, 2022
Transactions value $
$0
Form type
4
Date filed
3/4/2022, 09:06 AM
Previous filing
Dec 13, 2021
Next filing
Apr 26, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AIM Options Award $0 +50K $0.00 50K Mar 3, 2022 Common Stock 50K $0.70 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.